112 related articles for article (PubMed ID: 21787262)
1. Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma.
Kwee I; Capello D; Rinaldi A; Rancoita PM; Bhagat G; Greiner TC; Spina M; Gloghini A; Chan WC; Paulli M; Zucca E; Tirelli U; Carbone A; Gaidano G; Bertoni F
Leuk Lymphoma; 2012 Jan; 53(1):71-6. PubMed ID: 21787262
[TBL] [Abstract][Full Text] [Related]
2. EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.
Ferreiro JF; Morscio J; Dierickx D; Vandenberghe P; Gheysens O; Verhoef G; Zamani M; Tousseyn T; Wlodarska I
Am J Transplant; 2016 Feb; 16(2):414-25. PubMed ID: 26780579
[TBL] [Abstract][Full Text] [Related]
3. Mutational landscape of B-cell post-transplant lymphoproliferative disorders.
Menter T; Juskevicius D; Alikian M; Steiger J; Dirnhofer S; Tzankov A; Naresh KN
Br J Haematol; 2017 Jul; 178(1):48-56. PubMed ID: 28419429
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma.
Rinaldi A; Capello D; Scandurra M; Greiner TC; Chan WC; Bhagat G; Rossi D; Morra E; Paulli M; Rambaldi A; Rancoita PM; Inghirami G; Ponzoni M; Moreno SM; Piris MA; Mian M; Chigrinova E; Zucca E; Favera RD; Gaidano G; Kwee I; Bertoni F
Br J Haematol; 2010 May; 149(4):569-77. PubMed ID: 20230398
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
6. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
[TBL] [Abstract][Full Text] [Related]
7. Genome wide DNA-profiling of HIV-related B-cell lymphomas.
Capello D; Scandurra M; Poretti G; Rancoita PM; Mian M; Gloghini A; Deambrogi C; Martini M; Rossi D; Greiner TC; Chan WC; Ponzoni M; Moreno SM; Piris MA; Canzonieri V; Spina M; Tirelli U; Inghirami G; Rinaldi A; Zucca E; Favera RD; Cavalli F; Larocca LM; Kwee I; Carbone A; Gaidano G; Bertoni F
Br J Haematol; 2010 Jan; 148(2):245-55. PubMed ID: 19832807
[TBL] [Abstract][Full Text] [Related]
8. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
AbdullGaffar B; Seliem RM
Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
[TBL] [Abstract][Full Text] [Related]
9. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly.
Gebauer N; Gebauer J; Hardel TT; Bernard V; Biersack H; Lehnert H; Rades D; Feller AC; Thorns C
Leuk Lymphoma; 2015 Apr; 56(4):1100-6. PubMed ID: 25030036
[TBL] [Abstract][Full Text] [Related]
11. Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas.
Al-Humood SA; Al-Qallaf AS; Alshemmari SH; Francis IM; Junaid TA; Marouf RA; Al-Mulla F
J Histochem Cytochem; 2011 Oct; 59(10):918-31. PubMed ID: 21832150
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
[TBL] [Abstract][Full Text] [Related]
14. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
[TBL] [Abstract][Full Text] [Related]
15. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
Barrans SL; Evans PA; O'Connor SJ; Kendall SJ; Owen RG; Haynes AP; Morgan GJ; Jack AS
Clin Cancer Res; 2003 Jun; 9(6):2133-9. PubMed ID: 12796378
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
19. Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses.
Broséus J; Chen G; Hergalant S; Ramstein G; Mounier N; Guéant JL; Feugier P; Gisselbrecht C; Thieblemont C; Houlgatte R
Oncotarget; 2016 Dec; 7(51):83987-84002. PubMed ID: 27276707
[TBL] [Abstract][Full Text] [Related]
20. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]